This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB07165/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07165/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07165/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07165/identifier/drugbank/
n5http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07165
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n5:DB07165 n13:DB07165
dcterms:title
N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE
adms:identifier
n9:5CB n10:46937056 n11:DB07165 n12:99443636
n6:IUPAC-Name
n7:271B5065-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B506B-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B506A-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B5067-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B5068-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B5069-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B5063-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B5061-363D-11E5-9242-09173F13E4C5 n7:271B5064-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B5062-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B5071-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B5072-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B506C-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B506D-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B506F-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B506E-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B5070-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B5077-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B5079-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B507A-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B5076-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B5075-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B5078-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B5066-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B5073-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B5074-363D-11E5-9242-09173F13E4C5